Investor
Ideas Potcasts: Interview with Kaya Holdings (OTCQB: $KAYS) on the Sacred
Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health; @KayaHoldings
November 28, 2023 (Investorideas.com
Newswire), Investorideas.com, a global news source
covering leading sectors including marijuana and psychedelic stocks releases a
special edition of the top
rated Investor Ideas potcast (Cannabis Podcast).
In today’s episode, Investor Idea’s host Cali Van Zant speaks with CEO
Craig Frank and Senior Consultant Dave Jones of Kaya Holdings Inc (OTCQB: KAYS).
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2023/112223-Cannabis.mp3
Read this in full at https://www.investorideas.com/news/2023/cannabis-potcasts/11281Interview-Kaya-Holdings.asp
Kaya Holdings, Inc. is a mind care company focusing on wellness and
mental health through their operations in medical and recreational cannabis,
CBD products and psychedelic treatment clinics.
Kaya has the historical distinction of being the first US publicly
traded company to hold and operate cannabis licenses in “touch the plant”
categories from when it commenced cannabis operations in Portland, Oregon in
2014.
In today’s podcast, management discusses the new opportunities in the
medical psychedelic market and how Kaya Holdings is leading the way as an innovator
and pioneer in the sector. They also talk about their recent milestone of opening
one of the first state licensed Psilocybin Treatment Centers in the United
States, in Portland, Oregon.
Host Cali Van Zant says, “What makes this podcast special is to hear
management go deep and share their personal experiences and show that they care
about community. We discuss mental health and how it personally affects
us all. It is a rare opportunity to get such personal insight from a management
team and the opportunity to find a public company with heart. I hope you all enjoy
listening and share this interview.”
To learn more about Kaya holdings you can visit their website at (www.kayaholdings.com) or reach out to the team at info@kayaholdings.com
Today’s podcast overview
When
talking about the new Sacred Mushroom space, CEO
Craig Frank notes, “It is very important to us that the facility be
in a central location because we think community is a big part of the healing
process. We were very lucky to find the perfect location.”
“The space is the entire
top floor of the Falcon Building in downtown Portland. At about 11,000 square
feet, we have the area we need to offer both private and group experiences, as
well as creativity centers, sensory rooms, reflection areas, and the room to
roam and explore. We are equipped with a full kitchen and will be able to
provide food consistent with Oregon regulation….
I think there are four
primary differences between us and what we have seen so far. I would say the
first difference is the space itself. A huge contributing factor in the quality
of an experience is the setting and ours is extraordinary. Another difference
would be the extent to which we aim to cater the journey to individual
preference, with sound, sight, and scent options and the activity options
presented. Third, I would say the community we seek to create. While we will
cater to out-of-state visitors, our emphasis is on serving the needs of the
Greater Portland area. Finally, I would say our pricing model is different. We
are aiming to enable sustained treatment to those who seek it, so we have some
less expensive microdosing options.”
When
talking about other companies in the psilocybin
space, he went on to say, “The work of companies
like ATAI Life Sciences (NASDAQ:
ATAI) and Compass Pathways (NASDAQ:CMPS) is fascinating and we are excited to see what
their research can teach all of us about the medicinal possibilities of
psilocybin.
CMPS is developing its
own synthetic versions of that they then plan to administer in their own
treatment facilities. Our model calls for the use of natural psilocybin and
psilocin in our own facilities. We
believe our model is more immediate and allows us to avoid the long, laborious,
and very costly FDA process. We expect to begin offering treatments immediately
upon licensing of our facility…”
When
talking about the personal reasons for building a treatment center and working
in the Psilocybin space,
Frank says, “I would say that it is
hard to find an American family that does not have someone with a mental
disorder effecting their personal story whether it be a sibling, a parent, a
child, or a friend. There is something in the way we live that causes profound pain
and disorder in some people and our involvement is in some ways motivated to
bring this relief; to those we love and those other people love.”
About Kaya Holdings, Inc. (www.kayaholdings.com )
Kaya Holdings, Inc
is a "mind care" company with operations in medical/recreational
cannabis and pending operations in the emerging psilocybin sector. KAYS is a
fully reporting, US-based publicly traded company, listed for trading on the
over-the-counter market under the symbol KAYS.
In 2014, KAYS
became the first US public company to own and operate a medical cannabis
dispensary (in Portland, Oregon). The Company still operates the original Kaya
Shack™ cannabis dispensary while seeking to shift our cannabis operations to
serve the European Union. KAYS has interests in three medical cannabis licenses
(2 in Greece, 1 in Israel) to advance this effort.
Resuming its role
as innovator and trend setter, the Company is again breaking ground in the
United States with the planned introduction of psilocybin treatment centers
through our majority owned subsidiary, Fifth Dimension Therapeutics, Inc.
("FDT").
About Investorideas.com -
Big Investing Ideas
Investorideas.com is a platform for investing ideas. We
publish breaking stock news, stock research, guest posts and create original
top rated investing podcasts, plus sector tag articles featuring up and coming
companies and industry leaders. Investor
Idea’s original branded content includes the Crypto
Corner Podcast , Play by Play Sports Podcast , Cannabis
News and Stocks on the Move Podcast , Cleantech and Climate Change Podcast, Exploring Mining Podcast , Betting on Gaming Stocks Podcast
and the AI Eye Podcast. We
also create free investor stock directories for AI and tech, biotech, cannabis,
cleantech, crypto, defense, gaming, health and wellness, mining, oil and gas,
sports and water.
To hear more Investorideas.com podcasts
visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also
available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio, Google Podcasts and most audio platforms available.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party
sourced news, articles and equity research as well as creates original content,
including video, interviews and articles. Original content created by
investorideas is protected by copyright laws other than syndication rights. Our
site does not make recommendations for purchases or sale of stocks, services or
products. Nothing on our sites should be construed as an offer or solicitation
to buy or sell products or securities. All investing involves risk and possible
losses. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Disclosure:
KAYS is a paid for monthly featured stock on Investorideas.com. Contact
management and IR of each company directly regarding specific questions. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your
news release and our other news services on the Investorideas.com
newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except
where permissible by law. Our site does not possess, distribute, or sell
cannabis products.
Follow us on Twitter
https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact Investorideas.com
800 665 0411
No comments:
Post a Comment